Literature DB >> 27357255

Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.

Anne Grete Semb1, Silvia Rollefstad1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27357255     DOI： 10.1038/nrrheum.2016.103

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Statin therapy might be beneficial for patients with ankylosing spondylitis.

Authors:  J C van Denderen; M J L Peters; V P van Halm; I E van der Horst-Bruinsma; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

2.  Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy.

Authors:  Fleur M van der Valk; Sophie J Bernelot Moens; Simone L Verweij; Aart C Strang; Aart J Nederveen; Hein J Verberne; Michael T Nurmohamed; Dominique L Baeten; Erik S G Stroes
Journal:  Ann Rheum Dis       Date:  2016-04-15       Impact factor: 19.103

3.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Authors:  E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

4.  Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.

Authors:  S Rollefstad; E Ikdahl; J Hisdal; I C Olsen; I Holme; H B Hammer; K T Smerud; G D Kitas; T R Pedersen; T K Kvien; A G Semb
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

5.  Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study.

Authors:  Inger Jorid Berg; Désirée van der Heijde; Hanne Dagfinrud; Ingebjørg Seljeflot; Inge Christoffer Olsen; Tore K Kvien; Anne Grete Semb; Sella A Provan
Journal:  J Rheumatol       Date:  2015-02-01       Impact factor: 4.666

6.  Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study.

Authors:  Alfonso Corrales; Carlos González-Juanatey; María E Peiró; Ricardo Blanco; Javier Llorca; Miguel A González-Gay
Journal:  Ann Rheum Dis       Date:  2013-03-16       Impact factor: 19.103

7.  Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic.

Authors:  Silvia Rollefstad; Tore K Kvien; Ingar Holme; Anne S Eirheim; Terje R Pedersen; Anne Grete P Semb
Journal:  Ann Rheum Dis       Date:  2012-12-22       Impact factor: 19.103

8.  Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention.

Authors:  S Rollefstad; E Ikdahl; J Hisdal; T K Kvien; T R Pedersen; I Holme; A G Semb
Journal:  Ann Rheum Dis       Date:  2014-04-03       Impact factor: 19.103

9.  Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.

Authors:  Anne Grete Semb; Tore K Kvien; David A DeMicco; Rana Fayyad; Chuan-Chuan Wun; John C LaRosa; John Betteridge; Terje R Pedersen; Ingar Holme
Journal:  Arthritis Rheum       Date:  2012-09

10.  Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.

Authors:  Eirik Ikdahl; Silvia Rollefstad; Jonny Hisdal; Inge C Olsen; Terje R Pedersen; Tore K Kvien; Anne Grete Semb
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.